Spotta team

Spotta secures £934k Seed funding led by Cambridge Angels and REMUS

FUNDING THE FUTURE OF PEST CONTROL

Spotta’s smart pest systems attracts $1.18 million in seed funding

EMBARGOED UNTIL 28 JULY 2020, 6AM BST: Investors have rewarded the commercial success of Spotta’s smart pest systems with a $1.18 million seed funding round. 

This investment reflects Spotta’s huge potential in global markets in farming, forestry, hospitality, and other sectors to solve the £320 bn ($400 bn) problem of insect pests while dramatically reducing pesticide use.

Representatives of Cambridge Angels and REMUS, a US-based VC firm, will join Spotta’s board as part of the £934,000 ($1,184,287*) investment deal. Other major investors include Martlet Capital, Wren Capital, and the Angel CoFund. 

Based in Cambridge, Spotta commercialised its first product in 2019 and has been recognised by the US-based Fast Company magazine as one of the AI and Data World Changing Ideas for 2020. UK Cleaning Services and Support Association (CSSA) also nominated Spotta as a finalist in the Innovation Showcase 2020. In addition to its Bed Pod product which monitors bed bugs in hotels and other multi-room accommodation offerings, Spotta is working with a major forest management organisation to develop an outdoor pest monitoring solution, and anticipates its technology being used in other applications including insect monitoring to help boost yields in agriculture.

Building from this highly successful launch, Spotta will use the new funding to continue hiring top talent, launch two new products, and enter into new international markets beyond its current presence in the UK, the US and Europe. Spotta aims to grow rapidly to support this expansion and continue its innovative use of AI and Internet of Things (IoT) to offer an accessible technological solution for pest detection.

Robert Fryers, CEO at Spotta, states: “For decades, pest management has been held back by laborious, error-prone manual monitoring. With our technology it is finally possible to change this and help industries around the world to make a step change from reactive to proactive management of pests. This will save billions and massively reduce the amount of pesticide used globally. We’re delighted to have strong support from a wide group of investors who share our vision. This funding will allow us to scale up our commercial operations and continue to address the £320bn global problem of insect pests.”

“We are at an exciting intersection of AI, environmental sustainability and IoT,” continues Fryers. “Our scalable, platform technology enables huge increases in productivity in a range of sectors including agriculture, forestry, textiles and hospitality. We are building a substantial, highly profitable business by giving our customers better tools for dealing with invasive and costly species.” 

Paul Anson, lead investor from the Cambridge Angels says: “Throughout its initial market roll-out with the Bed Pod, Spotta has proven that its pest detection and identification technology has real-world capabilities and delivers customer value in a global marketplace. This was a very strong follow-on round and that speaks to the capability of the management team and their execution success. We look forward to supporting Spotta as it continues on its commercial journey.”

“We’re excited about the Spotta team’s multidimensional technical expertise and the larger pest control space, which has been relatively untouched by digital innovation. Spotta’s expansion into the US specifically makes it an exciting time for the company and our partnership,” says Krishna K. Gupta, who is the CEO of REMUS and is joining the Spotta board. “We’re looking forward to working with them to deliver on their global vision.”

Tim Mills, managing partner of the Angel CoFund says: “The smart pest system that Spotta has developed is a great example of a product built to solve a specific, persistent problem very effectively. Not only is that the hallmark of some of the most successful startups but beginning in narrow application is also where AI use has proven most successful to date. This approach has allowed it to quickly enjoy commercial success and expand into new markets, and we look forward to seeing the team scale the product into other applications with this funding.” 

Find out more at spotta.co 

– Ends –

Notes to editors

For more information on Spotta, contact: 

Megan McIntyre, Haynes MarComs
e: [email protected] t: +44 (0)7981 930 304

About Spotta

Founded in 2018, Spotta is utilising the latest technology to revolutionise pest control, shifting the industry from reactive to proactive. The Spotta Bed Pods offer accommodation providers the first continuous monitoring system which can identify common pests – including bed bugs – removing the need for manual checks by staff. Spotta uses Artificial Intelligence to confirm the pests’ identity at the earliest point of introduction, sending an alert to hotel management, encouraging hotels to treat the problem before infestations occur.

Since February 2019, the Pods have been installed in popular hotels in the United Kingdom. The Bed Pods run off Spotta’s own long range, stable wireless network, with a low power image processing and communications system. Fuelled by a single battery which will last over a year, Spotta’s ‘fit and forget’ technology is a time-saver for housekeeping and maintenance staff, helps protect affected hotels against reputational damage, and minimises treatment costs and litigation fees – all of which can save hotels up to £67,200 per year (based on 200-room hotel).

Spotta was founded and is based in Cambridge, UK. Discover more at spotta.co 

About Cambridge Angels

Cambridge Angels is a group of more than 60 high-net worth investors who have proven experience as successful entrepreneurs in technology, internet, software, hardware, tools and technologies supporting healthcare and digital healthcare. Members invest in and mentor high quality start-up and early-stage companies in these sectors in Cambridge, London, Oxford and throughout the UK. Our Members have been responsible for a large number of the “Cambridge Phenomenon” success stories over recent years. Therefore, in addition to providing funding for early-stage companies, Cambridge Angels also offer start-ups the considerable benefit of a wide range of expertise, contacts and directly relevant experience in establishing and growing entrepreneurial businesses successfully. cambridgeangels.com 

About REMUS

REMUS is an early-stage venture capital firm focused on building, rather than betting on, technology and science-enabled companies. REMUS partners with rebels who have entrepreneurial audacity running through their veins. The firm helps them recruit transformational executives, close iconic customers, and execute data-driven strategic decisions, all in the pursuit of building lasting legends. Founded out of an MIT dorm room in 2008, REMUS is based across Boston, San Francisco, and London. Learn more at remuscap.com.

About the Angel CoFund

Launched in 2011, the Angel CoFund (ACF) is a privately managed and commercially focused institution that works alongside groups of business angels to invest in high potential SMEs across the UK, directly providing funding as well as encouraging the expansion and development of the business angel market.

To date the ACF has supported 80 companies (for example Ebury, Gousto, Crowd Vision and Hopster) providing more than £40 million in direct investment alongside more than £200m from business angels and other investors, making it one of the most active early stage investors in the country. The ACF is a long-term investor and, in aggregate, sets aside £1 of further capital for every £1 it invests. This model gives portfolio companies and co-investors the support they need to propel strong growth.

To find out more, please visit angelcofund.co.uk

About Martlet Capital

Martlet Capital is the investment arm of the Marshall of Cambridge group and has invested in more than 50 start-ups, since its launch in 2011. The Company provides patient capital for early-stage B2B deep technology and life science start-ups, with a primary focus on companies based in Cambridge. Their team is comprised of experienced investors and entrepreneurs. In addition to capital, they offer support, experience and a network of contacts. They have achieved several exits from their portfolio, from trade sales to global technology companies and IPO’s. Find out more about their investment criteria, team, and scaling portfolio at martletcap.com.

About Wren Capital

Wren Capital is an early stage angel investor in science, software and engineering. It’s managing partner, Rajat Malhotra, is the 2013 UK Business Angels Association Angel Investor of the Year. Founded in 2011, Wren is well established in the UK’s early stage investment ecosystem and regularly co-invests alongside leading VCs, EIS funds and notable private investors. Find out more at wrencapital.co.uk 

Manoj Ranaweera

Manoj has founded, failed and successfully exited from a number of technology product companies as well as support organisations since 2004. Among them, Northern Tech Awards and edocr.com were acquired by GP Bullhound and Accusoft, Inc respectively. Today, Manoj is building a trusted support network for technology companies. He is working with founding teams to help them accelerate including raising investment and M&A.